Cervical Cancer
📧 Sign up to get email alerts when something new happens for Cervical Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial [NA]
A clinical trial update examining self-testing options in the era of primary HPV screening for cervical cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
FDA approval · 2023-07-26FDA Approved: TIVDAK — Supplemental Application (SEAGEN INC.)
The FDA approved a supplemental application for Tivdak (tisotumab vedotin) from Seagen Inc., representing additional regulatory action on th…
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]
Phase 3 trial evaluating a quadrivalent HPV recombinant vaccine in Chinese healthy females was terminated.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer [Phase 1]
This Phase 1 trial evaluates atezolizumab given before and/or with chemoradiotherapy in node-positive stage IB2, II, IIIB, or IVA cervical c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-05Clinical Trial Update: Subjects With Metastatic or Locally Advanced Solid Tumors, and Expansion Into Select Solid Tumors (Cervical) [Phase 1, Phase 2]
Phase 1/2 trial update for a therapy in cervical cancer and expansion into select solid tumors; study status completed.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study） [Phase 4]
Phase 4 clinical trial update for the CITRUS study assessing HPV testing intervention for cervical cancer screening. Completed status.
-
FDA approval · 2023-06-16FDA Approved: CARBOPLATIN — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for generic carboplatin. This action permits Apotex to market a generic carboplatin for…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age [Phase 3]
A Phase 3 trial comparing immunogenicity of a recombinant HPV nonavalent vaccine against Gardasil 9 in healthy women aged 18-26 has complete…
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical Cancer [Phase 2]
Phase 2 trial update evaluating caldonirimab plus nimotuzumab for recurrent or metastatic cervical cancer.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer [Phase 2]
Phase 2 trial update for bintrafusp alfa monotherapy in platinum-experienced cervical cancer (uterine cervical neoplasms) with completed sta…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Smoking Cessation for Cervical Cancer Survivors [NA]
Completed clinical trial on smoking cessation interventions for cervical cancer survivors; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer [Phase 2]
Phase 2 clinical trial update evaluating SHR-1210 in combination with apatinib for metastatic, persistent, or recurrent cervical cancer has …
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers [Phase 2]
Phase 2 trial update on atezolizumab and Vigil in advanced gynecological cancers, including ovarian, cervical, and uterine cancers, with com…
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer [Phase 3]
A Phase 3 clinical trial evaluating GLS-010 plus platinum-containing chemotherapy with or without bevacizumab as first-line therapy for pers…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer [Phase 1, Phase 2]
A Phase 1/2 study of ADXS11-001 or MEDI4736 alone or in combination for cervical cancer or HPV-associated head and neck cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer [Phase 2]
Phase 2 clinical trial evaluating anlotinib with concurrent chemoradiotherapy for locally advanced cervical cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Study of ADXS11-001 in Participants With High Risk Locally Advanced Cervical Cancer [Phase 3]
Phase 3 study of ADXS11-001 in high-risk locally advanced cervical cancer was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) [Phase 3]
Phase 3 CALLA trial evaluating durvalumab with chemoradiotherapy for locally advanced cervical cancer has completed enrollment and posted re…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Pap Smear Collection With the Papette Brush [NA]
Clinical trial update for Pap Smear collection using the Papette Brush in cervical cancer screening; trial completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer [Phase 2]
Phase 2 trial evaluating atezolizumab and bevacizumab in patients with recurrent, persistent, or metastatic cervical cancer; results availab…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer [Phase 3]
Phase 3 clinical trial evaluating concurrent chemoradiotherapy plus adjuvant chemotherapy for advanced cervical cancer is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors [Phase 2]
Phase 2 basket study evaluating simlukafusp alfa in combination therapy for advanced/metastatic solid tumors; study terminated with posted r…
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure [Phase 2]
Phase 2 trial updating cabozantinib in advanced or metastatic cervical cancer after platinum failure has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1) [Phase 3]
Phase 3 trial update evaluating SG001 plus chemotherapy ± bevacizumab versus placebo plus chemotherapy ± bevacizumab in PD-L1 positive cervi…